In marked contrast, chitin monotherapy significantly reduced 4T1 primary tumor growth (Fig. 1B,D) and also showed a growth reductive effect in 66cl4 primary tumors (Fig. 1C,E), albeit not statistically significant, compared to untreated and anti-PD-1-treated tumor-bearing mice. Here, PDCD1 is linked to neoplasm.